Janel Long-Boyle

1.6k total citations
43 papers, 578 citations indexed

About

Janel Long-Boyle is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Janel Long-Boyle has authored 43 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 20 papers in Public Health, Environmental and Occupational Health and 12 papers in Genetics. Recurrent topics in Janel Long-Boyle's work include Hematopoietic Stem Cell Transplantation (23 papers), Acute Lymphoblastic Leukemia research (20 papers) and Renal Transplantation Outcomes and Treatments (9 papers). Janel Long-Boyle is often cited by papers focused on Hematopoietic Stem Cell Transplantation (23 papers), Acute Lymphoblastic Leukemia research (20 papers) and Renal Transplantation Outcomes and Treatments (9 papers). Janel Long-Boyle collaborates with scholars based in United States, United Kingdom and Australia. Janel Long-Boyle's co-authors include Christopher C. Dvorak, Morton J. Cowan, Jason Law, Lisa Musick, Biljana Horn, Deborah French, Imke H. Bartelink, Liusheng Huang, Sandhya Kharbanda and Pamala A. Jacobson and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Oncotarget.

In The Last Decade

Janel Long-Boyle

40 papers receiving 568 citations

Peers

Janel Long-Boyle

HEMAT

PHEOH

PPCH

IMMUN

ONCOL

M Bouvier United States

Doris Drach United States

Jieyu Ye China

Kinjal Sanghavi United States

MS Hershfield United States

Renate Schottmann Germany

Aurélie Pétain France

JL Maddocks United Kingdom

Jinjing Wang China

J.F. Subra France

M Bouvier United States

Janel Long-Boyle

427 ×1.5

HEMAT

126 ×0.8

PHEOH

84 ×0.7

PPCH

143 ×1.3

IMMUN

175 ×1.7

ONCOL

Citations per year, relative to Janel Long-Boyle Janel Long-Boyle (= 1×) peers M Bouvier

Countries citing papers authored by Janel Long-Boyle

Since Specialization

Citations

This map shows the geographic impact of Janel Long-Boyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janel Long-Boyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janel Long-Boyle more than expected).

Fields of papers citing papers by Janel Long-Boyle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janel Long-Boyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janel Long-Boyle. The network helps show where Janel Long-Boyle may publish in the future.

Co-authorship network of co-authors of Janel Long-Boyle

This figure shows the co-authorship network connecting the top 25 collaborators of Janel Long-Boyle. A scholar is included among the top collaborators of Janel Long-Boyle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janel Long-Boyle. Janel Long-Boyle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dvorak, Christopher C., Soohee Cho, Christine S. Higham, et al.. (2025). High Melphalan Exposure Increases the Risk of Graft-Versus-Host Disease in Pediatric Patients Undergoing Alpha-Beta T-Cell Depleted Haploidentical Transplantation. Transplantation and Cellular Therapy. 31(6). 384.e1–384.e15.

Higham, Christine S., Kristin A. Shimano, Sandhya Kharbanda, et al.. (2024). Cyclophosphamide and Thiotepa Increases Risk of Transplant-Associated Thrombotic Microangiopathy. Transplantation and Cellular Therapy. 30(9). 931.e1–931.e10. 2 indexed citations

Dvorak, Christopher C., Janel Long-Boyle, Hisham Abdel‐Azim, et al.. (2024). Effect of rabbit ATG PK on outcomes after TCR-αβ/CD19–depleted pediatric haploidentical HCT for hematologic malignancy. Blood Advances. 8(23). 6003–6014. 3 indexed citations

Long-Boyle, Janel, et al.. (2024). Pharmacokinetics of Briquilimab as a Conditioning Agent for Hematopoietic Stem Cell Transplantation in Patients With Severe Combined Immunodeficiency, Myelodysplastic Syndrome, or Acute Myeloid Leukemia. Transplantation and Cellular Therapy. 30(9). 923.e1–923.e9. 1 indexed citations

Huynh, Van, Anurag K. Agrawal, Christine L. Phillips, et al.. (2023). Asparaginase-Associated Toxicities and Hypersensitivity Reactions in Pediatric and Adolescent Down Syndrome Patients with Acute Lymphoblastic Leukemia or Lymphoma. Blood. 142(Supplement 1). 5809–5809.

Long-Boyle, Janel, Donald B. Kohn, Ami J. Shah, et al.. (2023). Busulfan and subsequent malignancy: An evidence‐based risk assessment. Pediatric Blood & Cancer. 71(1). e30738–e30738. 3 indexed citations

Lü, Ying, Sandhya Kharbanda, Christopher C. Dvorak, et al.. (2022). Prospective Validation and Refinement of a Population Pharmacokinetic Model of Fludarabine in Children and Young Adults Undergoing Hematopoietic Cell Transplantation. Pharmaceutics. 14(11). 2462–2462. 6 indexed citations

Higham, Christine S., Kristin A. Shimano, Alexis Melton, et al.. (2021). Transplant-associated thrombotic microangiopathy in pediatric patients: pre-HSCT risk stratification and prophylaxis. Blood Advances. 5(8). 2106–2114. 16 indexed citations

Illamola, Sílvia M., Cathryn Jennissen, Susan E. Long, et al.. (2021). Busulfan dose Recommendation in Inherited Metabolic Disorders: Population Pharmacokinetic Analysis. Transplantation and Cellular Therapy. 28(2). 104.e1–104.e7. 4 indexed citations

10.

Keizer, Ron J., et al.. (2021). Population Pharmacokinetic Model Development of Tacrolimus in Pediatric and Young Adult Patients Undergoing Hematopoietic Cell Transplantation. Frontiers in Pharmacology. 12. 750672–750672. 6 indexed citations

11.

Agarwal, Rajni, Christopher C. Dvorak, Hye‐Sook Kwon, et al.. (2019). Non-Genotoxic Anti-CD117 Antibody Conditioning Results in Successful Hematopoietic Stem Cell Engraftment in Patients with Severe Combined Immunodeficiency. Blood. 134(Supplement_1). 800–800. 19 indexed citations

12.

Long-Boyle, Janel, Deborah French, Leslie Wilson, et al.. (2018). A practical first step using needs assessment and a survey approach to implementing a clinical pharmacogenomics consult service. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 2(3). 214–221. 8 indexed citations

13.

Ivaturi, Vijay, Christopher C. Dvorak, Tao Liu, et al.. (2017). Pharmacokinetics and Model-Based Dosing to Optimize Fludarabine Therapy in Pediatric Hematopoietic Cell Transplant Recipients. Biology of Blood and Marrow Transplantation. 23(10). 1701–1713. 40 indexed citations

14.

Czechowicz, Josephine A., Janel Long-Boyle, Kristina W. Rosbe, et al.. (2017). Sirolimus for management of complex vascular anomalies – A proposed dosing regimen for very young infants. International Journal of Pediatric Otorhinolaryngology. 105. 48–51. 22 indexed citations

15.

Long-Boyle, Janel, et al.. (2015). Predicting Pediatric Drug Disposition-Present and Future Directions of Pediatric Physiologically-Based Pharmacokinetics. Drug Metabolism Letters. 9(2). 80–87. 5 indexed citations

16.

Long-Boyle, Janel, Rada Savic, Imke H. Bartelink, et al.. (2014). Population Pharmacokinetics of Busulfan in Pediatric and Young Adult Patients Undergoing Hematopoietic Cell Transplant. Therapeutic Drug Monitoring. 37(2). 236–245. 66 indexed citations

17.

Huang, Liusheng, Patricia Lizak, Christopher C. Dvorak, Francesca Aweeka, & Janel Long-Boyle. (2014). Simultaneous determination of fludarabine and clofarabine in human plasma by LC–MS/MS. Journal of Chromatography B. 960. 194–199. 16 indexed citations

18.

Savić, Radojka M., Morton J. Cowan, Christopher C. Dvorak, et al.. (2013). Effect of Weight and Maturation on Busulfan Clearance in Infants and Small Children Undergoing Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 19(11). 1608–1614. 51 indexed citations

19.

Law, Jason, Morton J. Cowan, Christopher C. Dvorak, et al.. (2012). Busulfan, Fludarabine, and Alemtuzumab As a Reduced Toxicity Regimen for Children with Malignant and Nonmalignant Diseases Improves Engraftment and Graft-versus-Host Disease without Delaying Immune Reconstitution. Biology of Blood and Marrow Transplantation. 18(11). 1656–1663. 35 indexed citations

20.

Jacobson, Pamala A., John Rogosheske, A. G. Kerr, et al.. (2009). Comparison of two mycophenolate mofetil dosing regimens after hematopoietic cell transplantation. Bone Marrow Transplantation. 44(2). 113–120. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact